Condition
Lung Lesions
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07334990Not ApplicableNot Yet Recruiting
Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung Cancer
NCT07006311Not ApplicableRecruitingPrimary
Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol
NCT07060378Not ApplicableRecruitingPrimary
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
Showing all 3 trials